Opalesque Industry Update - Hedge Funds gained 0.62% in November according to the Barclay Hedge Fund Index compiled by BarclayHedge. The index is up 9.08% in 2017, and has had 13 consecutive winning months during which it gained 11.20% return. "The possibility that the US Senate might pass a tax bill rallied domestic equity markets," says Sol Waksman, founder and president of BarclayHedge. "For each of the past 13 months, the monthly close of the S&P 500 has set a new record high." Once again, the Technology Index powered upward with a 3.63% return in November. Technology has had 12 months of gains in the past 13 months, and is now up 25.29% for the year. The Healthcare and Biotechnology Index bounced back from a 1.57% loss in October with a 2.98% gain in November. Equity Long Bias was up 1.63%, Emerging Markets added 0.64%, Distressed Securities were up 0.59%, and Pacific Rim Equities rose 0.33%. Eight hedge fund indices lost ground in November. The Merger Arbitrage Index was down 0.79%, European Equities gave up 0.57%, Fixed Income Arbitrage lost 0.30%, and Convertible Arbitrage slid 0.21%. All of Barclay's 17 hedge fund indices are profitable after eleven months. Following the strong performance of the Technology Index, Healthcare & Biotechnology is up 18.70% for the year, Emerging Markets have gained 16.40%, Pacific Rim Equities are up 13.18%, and the Equity Long Bias Index has added 12.67%. The Barclay Fund of Funds Index lost 0.03% in November, but is up 5.66% for the year. |
Industry Updates
Barclay Hedge Fund Index Up 0.62% in November (+9.08% YTD)
Thursday, December 14, 2017
|
|